Early Rate Ends April 17, 2012.
Standard Rate Ends June 4, 2012.
Mauricio Futran is Professor and Chair of Chemical and Biochemical Engineering at Rutgers University. He came to this position after 28 years of pharmaceutical product and process development work at Merck and Co. and Bristol-Myers Squibb, where he was Vice President of Process R&D. His areas of expertise include all aspects of process development, technology transfer, validation, regulatory compliance, new product registration worldwide, external manufacturing and partnership development. He is a recognized leader in applying automation, physical property prediction and modeling to process development.
Professor Futran is a member of the National Academy of Engineering, the current chair of its Chemical Engineering section, and has served on its peer committee. He is also a member of the Board of Chemical Sciences and Technology, and an NRC panel. As an AIChE member he serves on the awards committee. He is a member (and former chair) of the Princeton Chemical and Biological Engineering external board, and has been a member of the external boards for the University of Illinois at Urbana Champaign, Georgia Tech, and Rutgers.
Other Confirmed Speakers include:
Dr. Monty Alger, Vice President and Chief Technology Officer, Air Products and Chemicals
Dr. David Berg, Technology Group Leader, DuPont
Dr. John Dillon, Vice President of API Operations, Pfizer Global Supply
Mr. Brad Duckworth, Group Leader, Eastman Chemical Company
Mr. Dennis Hendershot, Center for Chemical Process Safety, Consultant
Mr. Jack Hipple, Principal, Innovation TRIZ
Dr. Kevin Joback, President, Molecular Knowledge Systems
Dr. Martin D. Johnson, Chemical Product R&D, Eli Lilly and Company
Mr. Ron Leng, Research Fellow, Dow Chemical Company
Mr. John Peragine, Senior Principal Technical Investigator, Bristol-Myers Squibb
Mr. Michael Popule, PSC Reaction Engineering Group Manager, Air Products
Ms. Joan Roller, Business Development Manager, CRI
Dr. Michael Schaller, Global Process Technology Risk Assessment Leader, Dow Chemical
Dr. Michael Schultz, Vice President of Process Development, LanzaTech
Dr. Mark Shmorhun, Director Scale-Up and Technology Transfer, Myriant Corporation
Dr. Shankar Vaidyaraman, Chemical Product R&D, Eli Lilly and Company
Mr. Steven M. Weisser, Senior Scientist, GlaxoSmithKline
To read abstracts of these presentations, please visit the Program page.